
The board of GN Store Nord with Chairman Per Wold-Olsen at the Helm opposed LD Pensions' and Akademikerpension's shareholder proposals that tax information should be made public on a country-by-country basis as per 2021. The proposal was supported by boards in many other C25 companies, such as Chr. Hansen, Coloplast, Carlsberg ans FLSmidth.
GN's board, however, could not pull a majority against the proposal of looking into the possibility of increasing the transparency of GN's tax payments. The board's motion to dismiss the proposal had no effect on the shareholders. The proposal was passed at the general assembly with two-thirds of the votes, and with the support of for example Danske Bank, Nordea and Vanguard.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
In a world of options, Genmab's CEO chose partnerships
In 2015, Genmab partnered with relatively unknown biotech firm Biontech. Reflecting on how far Genmab has come since, CEO Jan van de Winkel is still confident that partnerships, rather than acquisitions, are the way forward. If it had acquired Biontech at the time, the CEO speculates Genmab may have put a stop to other activities – including the Covid-19 vaccine efforts that went on to save millions of lives. This and fairness are worth remembering as biotech firms are increasingly strapped for cash, van de Winkel reflects.